Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Exclusion Criteria

• •1. Known contraindication to either study vaccine (see product package inserts)
• •2. Receipt of any other influenza or other vaccine within 30 days prior to enrollment in this study.
• •3. Receipt of any new medication within 30 days prior to enrollment in this study
• •4. Plans to participate in any investigation involving an investigational product during this study.
• •5. Pre-existence of atopic dermatitis or any other cutaneous disorder that could complicate the evaluation of potential primary endpoints.
• •6. Any clinical or social circumstance that in the opinion of the investigator could interfere with compliance with study procedures or interfere with the interpretation of clinical data.